$PPCH - Investment Highlights Targeted therapy
Post# of 144167
![Avatar](/images/ProfileImages/734810790_1098_wst.png)
Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist .
Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of administration and potential new targets
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)